Laboratory Monitoring and Measuring of Clinical Anticoagulants
Seminars in Thrombosis and Hemostasis · 2026-11 · 52 (08) · 927-936
DOI: 10.1055/a-2907-8841 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 13.07.2026. Verfasst von Emmanuel J Favaloro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Departm…. Hauptthemen laut MEDLINE: Anticoagulants, Drug Monitoring, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Haemostasis reflects a balance between procoagulant and anticoagulant forces. A relative excess of procoagulant forces and/or a relative lack of anticoagulant forces can predispose individuals to an increased risk of thrombosis. Conversely, a relative lack of procoagulant forces and/or a relative excess of anticoagulant forces can predispose individuals to an increased risk of bleeding. It is possible in several clinical situations to mitigate bleeding risk using various approaches, including provision of procoagulant material; conversely, thrombosis risk can be mitigated by using various clinical anticoagulants. In some cases, such therapies require laboratory monitoring or measurements; in particular, therapy using anticoagulants may require laboratory measuring or monitoring to ensure adequate anticoagulation without over- or under-coagulating patients, and thereby reducing any treatment associated risk of bleeding or thrombosis. In this narrative review, we detail the various anticoagulants under current clinical use, as well as the tests or assays used to measure anticoagulant levels, or to monitor anticoagulant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Department of Haematology, New South Wales, Australia, Westmead.
- Sydney Centres for Thrombosis and Haemostasis, Research and Education Network, Westmead Hospital, New South Wales, Australia, Westmead.
- Charles Sturt University, School of Dentistry and Medical Sciences, New South Wales, Australia, Wagga Wagga.
- University of Sydney, Westmead Hospital, School of Medical Sciences, New South Wales, Australia, Westmead.
- The University of Newcastle Australia, School of Medicine and Public Health, New South Wales, Australia, Newcastle.
- Calvary Mater Hospital Newcastle, Department of Haematology, New South Wales, Australia, Waratah.
ORCID-Profile: Emmanuel J Favaloro, Benjamin Reardon, Leonardo Pasalic
Zitieren
APA
Favaloro, E. J., Reardon, B., & Pasalic, L. (2026). Laboratory Monitoring and Measuring of Clinical Anticoagulants. Seminars in Thrombosis and Hemostasis, 52(08), 927-936. https://doi.org/10.1055/a-2907-8841
Vancouver
Favaloro EJ, Reardon B, Pasalic L. Laboratory Monitoring and Measuring of Clinical Anticoagulants. Seminars in Thrombosis and Hemostasis. 2026;52(08):927-936. doi:10.1055/a-2907-8841
BibTeX
@article{Favaloro2026,
author = {Favaloro, Emmanuel J and Reardon, Benjamin and Pasalic, Leonardo},
title = {Laboratory Monitoring and Measuring of Clinical Anticoagulants},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2026},
volume = {52},
number = {08},
pages = {927--936},
doi = {10.1055/a-2907-8841}
}
EUVIMED